Please assess the completion status of the following clinical trial:

Trial Title: Absorption, Metabolism and Excretion (AME) of Single Dose Radiolabeled Prucalopride Succinate in Volunteers

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: OTHER
- Time Perspective: None
- Masking: NONE
- Phase: PHASE1
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Males aged between 18 and 50 years, inclusive~* Body mass index (BMI) of ≥18 and ≤30 kg/m2~* No more than 2 bowel movements per day or fewer than 3 bowel movement per week~* Provision of signed and dated, written informed consent prior to any study specific procedures~Exclusion Criteria:~* Have participated in a \[14C\]-study within the last 6 months.~* Exposure to clinically significant radiation within 12 months prior to dose (for example, serial X-ray or computed tomography scans, barium meal, current employment in a job requiring radiation exposure monitoring).~* Male subjects who consume more than 21 units of alcohol per week or 3 units per day.

- Gender: MALE
- Minimum Age: 18 Years
- Maximum Age: 50 Years
- Healthy Volunteers: t

Study Arms:
- Radiolabeled Prucalopride Succinate (Type: EXPERIMENTAL): None

Based on this trial design, predict the completion outcome and termination type (if applicable).